Insulinotropic activity of sulfonylurea/pullulan conjugate in rat islet microcapsule
Source abstract
Abstract
The in vitro long-term effect of a water-soluble sulfonylurea/pullulan conjugate (SUP) on insulinotropic activity and cell viability was investigated using rat pancreatic islets co-entrapped with SUP in conventional alginate-poly(L-lysine) microcapsules. The conjugate was synthesized by coupling a carboxylated glibenclamide derivative to a polysaccharide, pullulan (MW=200,000). In vitro static experiment showed that sulfonylurea concentration in SUP over 50 microM was required to stimulate the rat islets. In a dynamic insulin secretion test, the microcapsules of islets with SUP regained the insulin secretion pattern comparable to that of free islets, while those without SUP showed impaired insulin secretion. The long-term (1 month) culture experiment demonstrated that the microcapsules of islets with SUP, with well-preserved morphology, presented higher insulin secretion level and better ability in responding to glucose changes than those without SUP.
Source: europepmc · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Pancreatic function and diabetes · Diabetes Management and Research · Diabetes and associated disorders
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (39)
Show source-provided references
1. Bioengineering in development of the hybrid artificial pancreas10.1115/1.2891229 ↗
2. Islet transplantation with immunoisolation10.2337/diab.41.12.1503 ↗
3. Mini-review10.1002/bit.260430717 ↗
4. Biohybrid artificial pancreas based on macrocapsule device10.1016/S0169-409X(98)00077-5 ↗
5. Implantable biohybrid artificial organs10.1177/096368979500400413 ↗
6. Critical mass of islets that function after implantation in a large mammalian
7. Effect of donor islet mass on metabolic normalization in streptozotocin-diabetic rats10.1007/BF00429090 ↗
8. Function and survival of macroencapsulated syngeneic islets transplanted into streptozocin-diabetic mice10.1097/00007890-199807150-00004 ↗
9. Stimulatory effect of a sulfonylurea analogue and its polymer conjugate on insulin secretion from rat islets10.1021/bp00030a007 ↗
10. Synthesis of sulfonylurea conjugated copolymer via PEO spacer and its in vitro short-term bioactivity in insulin secretion from islets of Langerhans10.1016/S0142-9612(98)00008-8 ↗
11. Interaction of sulfonylurea-conjugated polymer with insulinoma cell line of MIN6 and its effect on insulin secretion10.1002/1097-4636(200104)55:1<72::AID-JBM100>3.0.CO;2-K ↗
12. The effect of zinc-crystallized glucagon-like peptide 1 on insulin secretion of macroencapsulated pancreatic islets10.1089/107632701300003278 ↗
13. The effect of crosslinked hemoglobin on functionality and viability of microencapsulated pancreatic islets10.1089/107632702760184655 ↗
14. Evaluation of carboxymethylpullulan as a novel carrier for targeting immune tissues10.1023/A:1011040703915 ↗
15. Potential of polysaccharide anchored liposomes in drug delivery, targeting and immunization
16. Improved biocompatibility but limited graft survival after purification of alginate for micoencapsulation of pancreatic islets10.1007/s001250050673 ↗
17. Association between capsule diameter, adequacy of encapsulation, and survival of microencapsulated rat islets allografts10.1097/00007890-199610150-00004 ↗
18. Rapid assessment of islet cell viability by MTT assay after cold storage in different solution
19. Assessment of the reproducibility of alginate encapsulation of pancreatic islets using MTT colorimetric assay10.1177/096368979400300410 ↗
20. Assessment of islet cell viability using fluorescent dyes10.1007/BF00275748 ↗
21. Electrophysiology of the pancreatic β-cell10.1016/0079-6107(89)90013-8 ↗
22. Control of insulin secretion by sulfonylureas, meglitinide and diazoxide in relation to their binding to the sulfonylurea receptor in pancreatic islets10.1016/0006-2952(89)90327-4 ↗
23. Tissue specificity of sulfonylureas10.2337/diabetes.47.9.1412 ↗
24. Species differences in the induction of time-dependent potentiation of insulin secretion10.1210/endo.137.5.8612499 ↗
25. Long-term survival, morphology and in vitro function of isolated pig islets under different culture conditions10.1097/00007890-199906270-00006 ↗
26. Pulsatile insulin secretion
27. Glucose-induced oscillatory insulin secretion in perifused rat pancreatic islets and clonal beta-cells (HIT)
28. Correlated oscillations in glucose consumption, oxygen comsumption, and intracellular free Ca2+ in single islets of Langerhans10.1074/jbc.275.9.6642 ↗
29. Long-term function of porcine islets and single cells embedded in barium-alginate matrix10.1055/s-2007-1002077 ↗
30. Improved in vivo pancreatic islet function after prolonged in vitro islet culture10.1097/00007890-200112150-00005 ↗
31. Long-term survival morphology and in vitro function of isolated pig islets under different culture conditions10.1097/00007890-199906270-00006 ↗
32. Increased islet viability by addition of beraprost sodium to collagenase solution10.1097/00006676-200107000-00009 ↗
33. β-cell dysfunction induced by chronic hyperglycemia10.2337/diacare.15.3.442 ↗
34. Glucose toxicity10.2337/diacare.13.6.610 ↗
35. β-cell adaptation and decompensation during the progression of diabetes10.2337/diabetes.50.2007.S154 ↗
36. Perspective10.1210/endo.141.6.7567 ↗
37. β-cell turnover10.2337/diabetes.50.2007.S20 ↗
38. Pancreatic beta-cell growth and diabetes mellitus10.1007/BF00400917 ↗
39. Regulation of β-cell mass by hormones and growth factors10.2337/diabetes.50.2007.S25 ↗